Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

BeiGene Launches Guangzhou Innovation Center for Drug/Device Startups

publication date: Dec 24, 2021

BeiGene launched the BeiGene Bioisland Innovation Center (BIC) in Guangzhou with the goal of enabling scientists and entrepreneurs to develop novel cutting-edge medical innovations. The newcos will have potential access to BeiGene support over the complete development process. The incubator will house state-of-the-art laboratory equipment and comprehensive research capabilities. The BIC center, which will have an area of 39,948 square meters in the Guangdong-Hong Kong-Macao Greater Bay Area, will eventually be home to more than 30 startup companies. More details....

Stock Symbols: (NSDQ: BGNE; HK: 06160; SHA: 688235)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.